| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |